What does Skin Analytics do?
Skin Analytics is a medtech company focused on enhancing dermatological diagnostics through advanced artificial intelligence. Their flagship product, DERM, analyzes dermoscopic images to assess skin lesions and identify potential skin cancers.
How much did they raise?
The company raised £15M in a Series B round led by Intrepid Partners. This investment highlights continued confidence in their innovative approach to improving skin cancer detection.
What are their plans for the money?
With the new capital, Skin Analytics plans to expand its team, launch new dermatology products, and further its international expansion into markets like Europe and Australia, along with preparing for a US market launch. These steps are expected to boost efficiency in patient care and reduce delays in dermatological assessments.
What have they achieved so far?
Skin Analytics has already achieved significant regulatory milestones with its DERM AI device, which holds Class IIa UKCA and Class III CE marks. This technology has demonstrated potential in alleviating NHS backlogs by enabling earlier discharge of benign lesions and prioritizing care for patients with skin cancer.